Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Dexamethasone Implant for Retinal Detachment in Uveal Melanoma
Phase 1
- Conditions
- Exudative Retinal Detachment and Uveal Melanoma
- Interventions
- First Posted Date
- 2019-09-10
- Last Posted Date
- 2021-07-29
- Lead Sponsor
- Ivana K. Kim
- Target Recruit Count
- 20
- Registration Number
- NCT04082962
- Locations
- 🇺🇸
i. Ocular Melanoma Center, Massachusetts Eye and Ear, Boston, Massachusetts, United States
News
No news found